These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9645444)

  • 1. Expression of bcl-2 oncoprotein in transitional cell carcinoma of the upper urinary tract.
    Nakanishi K; Tominaga S; Kawai T; Torikata C; Aurues T; Ikeda T
    Virchows Arch; 1998 May; 432(5):445-50. PubMed ID: 9645444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of survivin does not predict survival in patients with transitional cell carcinoma of the upper urinary tract.
    Nakanishi K; Tominaga S; Hiroi S; Kawai T; Aida S; Kasamatsu H; Aurues T; Hayashi T; Ikeda T
    Virchows Arch; 2002 Dec; 441(6):559-63. PubMed ID: 12461612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical evaluation of p53 oncoprotein in transitional cell carcinoma of the upper urinary tract.
    Nakanishi K; Kawai T; Torikata C
    Hum Pathol; 1996 Dec; 27(12):1336-40. PubMed ID: 8958308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth factors and oncogene products in transitional cell carcinoma.
    Nakanishi K; Kawai T; Suzuki M; Torikata C
    Mod Pathol; 1996 Mar; 9(3):292-7. PubMed ID: 8685230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of p27(Kip1) protein in transitional cell carcinoma of the upper urinary tract.
    Nakanishi K; Kawai T; Aida S; Kasamatsu H; Aurues T; Ikeda T
    Mod Pathol; 2001 May; 14(5):371-6. PubMed ID: 11353044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-cadherin expression in upper-urinary-tract carcinoma.
    Nakanishi K; Kawai T; Torikata C; Aurues T; Ikeda T
    Int J Cancer; 1997 Aug; 74(4):446-9. PubMed ID: 9291437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of bcl-2 expression in transitional cell carcinoma of the bladder.
    Shiina H; Igawa M; Urakami S; Honda S; Shirakawa H; Ishibe T
    J Clin Pathol; 1996 May; 49(5):395-9. PubMed ID: 8707954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates.
    Nakopoulou L; Vourlakou C; Zervas A; Tzonou A; Gakiopoulou H; Dimopoulos MA
    Hum Pathol; 1998 Feb; 29(2):146-54. PubMed ID: 9490274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of p53, Ki-67 and matrix metalloproteinases MMP-2 and MMP-9 in transitional cell carcinoma of the renal pelvis and ureter.
    Kamijima S; Tobe T; Suyama T; Ueda T; Igarashi T; Ichikawa T; Ito H
    Int J Urol; 2005 Nov; 12(11):941-7. PubMed ID: 16351648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal expression of bcl-2 and p53 oncoproteins in urothelial dysplasia and carcinoma of the urinary bladder.
    Li B; Kanamaru H; Noriki S; Yamaguchi T; Fukuda M; Okada K
    Urol Res; 1998; 26(4):235-41. PubMed ID: 9759996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of hypoxia-inducible factor-1alpha protein predicts survival in patients with transitional cell carcinoma of the upper urinary tract.
    Nakanishi K; Hiroi S; Tominaga S; Aida S; Kasamatsu H; Matsuyama S; Matsuyama T; Kawai T
    Clin Cancer Res; 2005 Apr; 11(7):2583-90. PubMed ID: 15814637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma.
    Fromont G; Rouprêt M; Amira N; Sibony M; Vallancien G; Validire P; Cussenot O
    Eur Urol; 2005 Nov; 48(5):764-70. PubMed ID: 16126329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
    Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M
    Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of telomerase mRNA component (hTR) in transitional cell carcinoma of the upper urinary tract.
    Nakanishi K; Kawai T; Hiroi S; Kumaki F; Torikata C; Aurues T; Ikeda T
    Cancer; 1999 Nov; 86(10):2109-16. PubMed ID: 10570439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of telomerase catalytic subunit (hTERT) mRNA does not predict survival in patients with transitional cell carcinoma of the upper urinary tract.
    Nakanishi K; Hiroi S; Kawai T; Aida S; Kasamatsu H; Aurues T; Ikeda T
    Mod Pathol; 2001 Nov; 14(11):1073-8. PubMed ID: 11706066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of p53, MDM2 and bcl-2 expression in transitional cell carcinoma of the bladder.
    Uchida T; Minei S; Gao JP; Wang C; Satoh T; Baba S
    Oncol Rep; 2002; 9(2):253-9. PubMed ID: 11836589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in transitional cell cancer of the bladder: an emerging role for Bcl-2 and p53.
    Ong F; Moonen LM; Gallee MP; ten Bosch C; Zerp SF; Hart AA; Bartelink H; Verheij M
    Radiother Oncol; 2001 Nov; 61(2):169-75. PubMed ID: 11690683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of p53 and MDM2 in tumor proliferation and determination of the prognosis of transitional cell carcinoma of the renal pelvis and ureter.
    Hashimoto H; Sue Y; Saga Y; Tokumitsu M; Yachiku S
    Int J Urol; 2000 Dec; 7(12):457-63. PubMed ID: 11168685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of p27Kip1 and Ki-67 expression in carcinoma of the renal pelvis and ureter.
    Kamai T; Takagi K; Asami H; Ito Y; Arai K; Yoshida KI
    BJU Int; 2000 Jul; 86(1):14-9. PubMed ID: 10886076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.